Mirati Therapeutics, Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies that target the genetic drivers of cancer @Bristol Myers Squibb or www.bms.com
Looking for a particular Mirati Therapeutics employee's phone or email?
The Mirati Therapeutics annual revenue was $46.5 billion in 2026.
Hirak der-Torossian is the Vice President Clinical Development of Mirati Therapeutics.
132 people are employed at Mirati Therapeutics.
Mirati Therapeutics is based in San Diego, California.
The NAICS codes for Mirati Therapeutics are [33, 541712, 54171, 5417, 541, 54].
The SIC codes for Mirati Therapeutics are [283, 873, 28, 87].